(Q36682688)

15 August 2017

Infusion rate and pharmacokinetics of intravenous pamidronate in the treatment of tumour-induced hypercalcaemia (English)

1 reference

15 August 2017

1 reference

2

A. Howell

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1437922

26 September 2022

author name string

Daley-Yates PT

4

1 reference

15 August 2017

D. J. Dodwell

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1437922

26 September 2022

A. R. Morton

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1437922

26 September 2022

P. T. Daley-Yates

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1437922

26 September 2022

C. R. Hoggarth

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1437922

26 September 2022

language of work or name

English

0 references

publication date

1 June 1992

1 reference

full work available at URL

15 August 2017

https://europepmc.org/articles/PMC2399364

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1437922

https://europepmc.org/articles/PMC2399364?pdf=render

26 September 2022

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1437922

Postgraduate Medical Journal

26 September 2022

published in

1 reference

15 August 2017

68

1 reference

15 August 2017

800

1 reference

15 August 2017

434-439

1 reference

Treatment of bone metastases from breast cancer with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD).

15 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2399364

Effect of single high dose infusions of aminohydroxypropylidene diphosphonate on hypercalcaemia caused by cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2399364

Sclerosis of lytic bone metastases after disodium aminohydroxypropylidene bisphosphonate (APD) in patients with breast carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2399364

Absorption of oral diphosphonate in normal subjects

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2399364

Efficacious management with aminobisphosphonate (APD) in Paget's disease of bone

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2399364

Comparison of three intravenous bisphosphonates in cancer-associated hypercalcaemia

28 June 2018

1 reference

12 December 2020

A single-day treatment of tumor-induced hypercalcemia by intravenous amino-hydroxypropylidene bisphosphonate

1 reference

12 December 2020

Comparison of intravenous (3-amino-1-hydroxypropylidene)-1, 1-bisphosphonate and volume repletion in tumour-induced hypercalcaemia

1 reference

12 December 2020

Intravenous etidronate in the management of malignant hypercalcemia

1 reference

12 December 2020

Dose-response in the treatment of hypercalcemia of malignancy by a single infusion of the bisphosphonate AHPrBP

1 reference

12 December 2020

Two-year follow-up of biphosphonate (APD) treatment in steroid osteoporosis

1 reference

12 December 2020

Identifiers

DOI

10.1136/PGMJ.68.800.434

1 reference

15 August 2017

1 reference

15 August 2017

1 reference